CHIP'ing Signal from Noise in Liquid Biopsy

Area of Science:

• Oncology
• Genetics
• Molecular Diagnostics

Background:

• Cell-free DNA (cfDNA) analysis is vital for cancer detection and monitoring.
• Clonal hematopoiesis (CH) is the presence of somatic mutations in hematopoietic stem cells.
• CH variants in cfDNA can be mistaken for tumor-derived mutations.

Purpose of the Study:

• To highlight the challenge of differentiating cfDNA variants originating from CH versus tumors.
• To discuss the clinical implications of misinterpreting cfDNA variant origins.
• To emphasize the need for accurate variant source attribution in clinical practice.

Main Methods:

• Review of current literature on CH and cfDNA analysis.
• Discussion of diagnostic strategies for variant origin determination.
• Analysis of clinical case scenarios illustrating the impact of CH.

Main Results:

• CH variants can lead to false-positive cancer diagnoses or misinterpretations of treatment response.
• Failure to distinguish CH can result in unnecessary treatments or delayed/inappropriate cancer therapies.
• Distinguishing variant origins requires careful consideration of patient history and variant patterns.

Conclusions:

• Accurate identification of cfDNA variant origins (CH vs. tumor) is essential for reliable cancer diagnostics and treatment.
• Clinical guidelines and diagnostic tools are needed to address the impact of CH on cfDNA interpretation.
• Further research is warranted to improve methods for distinguishing CH from tumoral cfDNA.